Glatiramer Acetate
(YLOCGHYTXIINAI-XKUOMLDTSA-N)
Structure
- SMILES
- OC(=O)[C@H](Cc1ccc(cc1)O)N.C[C@@H](C(=O)O)N.OC(=O)CC[C@@H](C(=O)O)N.NCCCC[C@@H](C(=O)O)N
- Molecular Formula:
- C23H41N5O11
- Molecular Weight:
- 563.599
- Log P:
- 2.0567
- Hydrogen Bond Acceptor:
- 16
- Hydrogen Bond Donor:
- 11
- TPSA:
- 336.83
- CAS Number(s):
- 28704-27-0
Synonym(s)
1.
Glatiramer Acetate
2.
Copaxone
3.
Glatiramer
4.
TV 5010
5.
TV-5010
6.
TV5010
7.
5010, TV
8.
Acetate, Glatiramer
External Link(s)
| MeSH | D000068717 |
| PubChem Compound | 65370 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Product substitution issue | FAERS: 102 | US FAERS | |
| 2 | Injection site pain | FAERS: 93 | US FAERS | |
| 3 | Injection Site Reaction | FAERS: 87 | US FAERS | |
| 4 | Injection site erythema | FAERS: 67 | US FAERS | |
| 5 | Injection site pruritus | FAERS: 46 | US FAERS | |
| 6 | Headache | FAERS: 34 | US FAERS | |
| 7 | Injection site mass | FAERS: 34 | US FAERS | |
| 8 | Urticaria | FAERS: 34 | US FAERS | |
| 9 | Pruritus | FAERS: 31 | US FAERS | |
| 10 | Nausea | FAERS: 30 | US FAERS | |
| 11 | Product dose omission | FAERS: 30 | US FAERS | |
| 12 | Flushing | FAERS: 27 | US FAERS | |
| 13 | Therapy cessation | FAERS: 27 | US FAERS | |
| 14 | Injection site urticaria | FAERS: 26 | US FAERS | |
| 15 | Fatigue | FAERS: 25 | US FAERS | |
| 16 | Pain | FAERS: 25 | US FAERS | |
| 17 | Chest discomfort | FAERS: 21 | US FAERS | |
| 18 | Injection site bruising | FAERS: 17 | US FAERS | |
| 19 | Erythema | FAERS: 16 | US FAERS | |
| 20 | Tremor | FAERS: 16 | US FAERS | |
| 21 | Dizziness | FAERS: 15 | US FAERS | |
| 22 | Hypersensitivity | FAERS: 15 | US FAERS | |
| 23 | Burning sensation | FAERS: 14 | US FAERS | |
| 24 | Drug ineffective | FAERS: 14 | US FAERS | |
| 25 | Multiple sclerosis relapse | FAERS: 14 | US FAERS | |
| 26 | Drug dose omission | FAERS: 13 | US FAERS | |
| 27 | Chest Pain | FAERS: 12 | US FAERS | |
| 28 | Back Pain | FAERS: 11 | US FAERS | |
| 29 | Wrong technique in product usage process | FAERS: 11 | US FAERS | |
| 30 | Chills | FAERS: 10 | US FAERS | |
| 31 | Vomiting | FAERS: 10 | US FAERS | |
| 32 | Arthralgia | FAERS: 9 | US FAERS | |
| 33 | Malaise | FAERS: 9 | US FAERS | |
| 34 | Memory impairment | FAERS: 9 | US FAERS | |
| 35 | Swelling | FAERS: 9 | US FAERS | |
| 36 | Anxiety | FAERS: 8 | US FAERS | |
| 37 | Asthenia | FAERS: 8 | US FAERS | |
| 38 | Inability to afford medication | FAERS: 7 | US FAERS | |
| 39 | Multiple Sclerosis | FAERS: 7 | US FAERS | |
| 40 | Myalgia | FAERS: 7 | US FAERS | |
| 41 | Feeling Cold | FAERS: 6 | US FAERS | |
| 42 | Feeling abnormal | FAERS: 6 | US FAERS | |
| 43 | Injection site warmth | FAERS: 6 | US FAERS | |
| 44 | Post procedural complication | FAERS: 6 | US FAERS | |
| 45 | Cold sweat | FAERS: 5 | US FAERS | |
| 46 | Device difficult to use | FAERS: 5 | US FAERS | |
| 47 | Disease Progression | FAERS: 5 | US FAERS | |
| 48 | Hypotension | FAERS: 5 | US FAERS | |
| 49 | Insurance issue | FAERS: 5 | US FAERS | |
| 50 | Palpitations | FAERS: 5 | US FAERS | |
| 51 | Aphasia | FAERS: 4 | US FAERS | |
| 52 | Device malfunction | FAERS: 4 | US FAERS | |
| 53 | Drug administered in wrong device | FAERS: 4 | US FAERS | |
| 54 | Injection site vesicles | FAERS: 4 | US FAERS | |
| 55 | Muscle tightness | FAERS: 4 | US FAERS | |
| 56 | Product dispensing error | FAERS: 4 | US FAERS | |
| 57 | Product storage error | FAERS: 4 | US FAERS | |
| 58 | Tachycardia | FAERS: 4 | US FAERS | |
| 59 | Abdominal Pain | FAERS: 3 | US FAERS | |
| 60 | Abdominal discomfort | FAERS: 3 | US FAERS | |
| 61 | Acne | FAERS: 3 | US FAERS | |
| 62 | Amnesia | FAERS: 3 | US FAERS | |
| 63 | Disease recurrence | FAERS: 3 | US FAERS | |
| 64 | Gait inability | FAERS: 3 | US FAERS | |
| 65 | Immediate post-injection reaction | FAERS: 3 | US FAERS | |
| 66 | Inappropriate schedule of product administration | FAERS: 3 | US FAERS | |
| 67 | Injection related reaction | FAERS: 3 | US FAERS | |
| 68 | Injection site atrophy | FAERS: 3 | US FAERS | |
| 69 | Injection site indentation | FAERS: 3 | US FAERS | |
| 70 | Injection site inflammation | FAERS: 3 | US FAERS | |
| 71 | Injection site irritation | FAERS: 3 | US FAERS | |
| 72 | Injection site nodule | FAERS: 3 | US FAERS | |
| 73 | Intentional dose omission | FAERS: 3 | US FAERS | |
| 74 | Joint swelling | FAERS: 3 | US FAERS | |
| 75 | Lipoatrophy | FAERS: 3 | US FAERS | |
| 76 | Mouth swelling | FAERS: 3 | US FAERS | |
| 77 | Musculoskeletal stiffness | FAERS: 3 | US FAERS | |
| 78 | Neck Pain | FAERS: 3 | US FAERS | |
| 79 | Optic Neuritis | FAERS: 3 | US FAERS | |
| 80 | Product use complaint | FAERS: 3 | US FAERS | |
| 81 | Skin reaction | FAERS: 3 | US FAERS | |
| 82 | Syncope | FAERS: 3 | US FAERS | |
| 83 | Vertigo | FAERS: 3 | US FAERS | |
| 84 | Wrong schedule | FAERS: 3 | US FAERS | |
| 85 | Adverse event | FAERS: 2 | US FAERS | |
| 86 | Alopecia | FAERS: 2 | US FAERS | |
| 87 | Bone pain | FAERS: 2 | US FAERS | |
| 88 | Central nervous system lesion | FAERS: 2 | US FAERS | |
| 89 | Clumsiness | FAERS: 2 | US FAERS | |
| 90 | Constipation | FAERS: 2 | US FAERS | |
| 91 | Dehydration | FAERS: 2 | US FAERS | |
| 92 | Device Failure | FAERS: 2 | US FAERS | |
| 93 | Device damage | FAERS: 2 | US FAERS | |
| 94 | Discomfort | FAERS: 2 | US FAERS | |
| 95 | Economic problem | FAERS: 2 | US FAERS | |
| 96 | Hemiparesis | FAERS: 2 | US FAERS | |
| 97 | Inappropriate schedule of drug administration | FAERS: 2 | US FAERS | |
| 98 | Incorrect dose administered | FAERS: 2 | US FAERS | |
| 99 | Infection | FAERS: 2 | US FAERS | |
| 100 | Injection site hypersensitivity | FAERS: 2 | US FAERS | |
| 101 | Injection site papule | FAERS: 2 | US FAERS | |
| 102 | Injection site scar | FAERS: 2 | US FAERS | |
| 103 | Lip swelling | FAERS: 2 | US FAERS | |
| 104 | Loss of personal independence in daily activities | FAERS: 2 | US FAERS | |
| 105 | Pain of skin | FAERS: 2 | US FAERS | |
| 106 | Peripheral swelling | FAERS: 2 | US FAERS | |
| 107 | Pharyngeal swelling | FAERS: 2 | US FAERS | |
| 108 | Product quality issue | FAERS: 2 | US FAERS | |
| 109 | Stress | FAERS: 2 | US FAERS | |
| 110 | Therapy change | FAERS: 2 | US FAERS | |
| 111 | Therapy non-responder | FAERS: 2 | US FAERS | |
| 112 | Tinnitus | FAERS: 2 | US FAERS | |
| 113 | Unevaluable event | FAERS: 2 | US FAERS | |
| 114 | Vascular pain | FAERS: 2 | US FAERS | |
| 115 | Wrong device used | FAERS: 2 | US FAERS | |
| 116 | Wrong technique in device usage process | FAERS: 2 | US FAERS | |
| 117 | Abscess | FAERS: 1 | US FAERS | |
| 118 | Accidental exposure to product | FAERS: 1 | US FAERS | |
| 119 | Anaphylactic shock | FAERS: 1 | US FAERS | |
| 120 | Aneurysm | FAERS: 1 | US FAERS | |
| 121 | Anger | FAERS: 1 | US FAERS | |
| 122 | Angina Pectoris | FAERS: 1 | US FAERS | |
| 123 | Aphonia | FAERS: 1 | US FAERS | |
| 124 | Apparent death | FAERS: 1 | US FAERS | |
| 125 | Axonal neuropathy | FAERS: 1 | US FAERS | |
| 126 | Blindness | FAERS: 1 | US FAERS | |
| 127 | Blood iron decreased | FAERS: 1 | US FAERS | |
| 128 | Blood urine present | FAERS: 1 | US FAERS | |
| 129 | Bradycardia | FAERS: 1 | US FAERS | |
| 130 | Cerebral disorder | FAERS: 1 | US FAERS | |
| 131 | Congenital skin dimples | FAERS: 1 | US FAERS | |
| 132 | Crying | FAERS: 1 | US FAERS | |
| 133 | Cystitis | FAERS: 1 | US FAERS | |
| 134 | Device dispensing error | FAERS: 1 | US FAERS | |
| 135 | Device use error | FAERS: 1 | US FAERS | |
| 136 | Device-device incompatibility | FAERS: 1 | US FAERS | |
| 137 | Disorientation | FAERS: 1 | US FAERS | |
| 138 | Drooling | FAERS: 1 | US FAERS | |
| 139 | Drug administered to patient of inappropriate age | FAERS: 1 | US FAERS | |
| 140 | Drug administration error | FAERS: 1 | US FAERS | |
| 141 | Drug-device incompatibility | FAERS: 1 | US FAERS | |
| 142 | Dyspepsia | FAERS: 1 | US FAERS | |
| 143 | Ear discomfort | FAERS: 1 | US FAERS | |
| 144 | Eosinophilic pleural effusion | FAERS: 1 | US FAERS | |
| 145 | Epistaxis | FAERS: 1 | US FAERS | |
| 146 | Erythema Multiforme | FAERS: 1 | US FAERS | |
| 147 | Extra dose administered | FAERS: 1 | US FAERS | |
| 148 | Eye Infection | FAERS: 1 | US FAERS | |
| 149 | Flank Pain | FAERS: 1 | US FAERS | |
| 150 | Flatulence | FAERS: 1 | US FAERS | |
| 151 | Head discomfort | FAERS: 1 | US FAERS | |
| 152 | Hospice Care | FAERS: 1 | US FAERS | |
| 153 | Hypersomnia | FAERS: 1 | US FAERS | |
| 154 | Hyperventilation | FAERS: 1 | US FAERS | |
| 155 | Hypokinesia | FAERS: 1 | US FAERS | |
| 156 | Impaired driving ability | FAERS: 1 | US FAERS | |
| 157 | Impaired gastric emptying | FAERS: 1 | US FAERS | |
| 158 | Impaired work ability | FAERS: 1 | US FAERS | |
| 159 | Induration | FAERS: 1 | US FAERS | |
| 160 | Influenza | FAERS: 1 | US FAERS | |
| 161 | Injection site discomfort | FAERS: 1 | US FAERS | |
| 162 | Injury associated with device | FAERS: 1 | US FAERS | |
| 163 | Intestinal Obstruction | FAERS: 1 | US FAERS | |
| 164 | Intestinal Pseudo-Obstruction | FAERS: 1 | US FAERS | |
| 165 | Laceration | FAERS: 1 | US FAERS | |
| 166 | Lethargy | FAERS: 1 | US FAERS | |
| 167 | Lipodystrophy acquired | FAERS: 1 | US FAERS | |
| 168 | Lymphadenopathy | FAERS: 1 | US FAERS | |
| 169 | Lymphangioma | FAERS: 1 | US FAERS | |
| 170 | Manufacturing product shipping issue | FAERS: 1 | US FAERS | |
| 171 | Manufacturing product storage issue | FAERS: 1 | US FAERS | |
| 172 | Maternal exposure during pregnancy | FAERS: 1 | US FAERS | |
| 173 | Muscle Spasticity | FAERS: 1 | US FAERS | |
| 174 | Musculoskeletal Pain | FAERS: 1 | US FAERS | |
| 175 | Myocardial Infarction | FAERS: 1 | US FAERS | |
| 176 | Nephrolithiasis | FAERS: 1 | US FAERS | |
| 177 | Nerve injury | FAERS: 1 | US FAERS | |
| 178 | Nervousness | FAERS: 1 | US FAERS | |
| 179 | Neuralgia | FAERS: 1 | US FAERS | |
| 180 | Neutropenia | FAERS: 1 | US FAERS | |
| 181 | No adverse event | FAERS: 1 | US FAERS | |
| 182 | No reaction on previous exposure to drug | FAERS: 1 | US FAERS | |
| 183 | Oropharyngeal pain | FAERS: 1 | US FAERS | |
| 184 | Pallor | FAERS: 1 | US FAERS | |
| 185 | Pancreatic Cyst | FAERS: 1 | US FAERS | |
| 186 | Pancreatic carcinoma | FAERS: 1 | US FAERS | |
| 187 | Pneumothorax | FAERS: 1 | US FAERS | |
| 188 | Poor quality sleep | FAERS: 1 | US FAERS | |
| 189 | Pregnancy | FAERS: 1 | US FAERS | |
| 190 | Product availability issue | FAERS: 1 | US FAERS | |
| 191 | Product distribution issue | FAERS: 1 | US FAERS | |
| 192 | Product outer packaging issue | FAERS: 1 | US FAERS | |
| 193 | Product prescribing issue | FAERS: 1 | US FAERS | |
| 194 | Product substitution | FAERS: 1 | US FAERS | |
| 195 | Product substitution error | FAERS: 1 | US FAERS | |
| 196 | Progressive multiple sclerosis | FAERS: 1 | US FAERS | |
| 197 | Rash erythematous | FAERS: 1 | US FAERS | |
| 198 | Respiratory arrest | FAERS: 1 | US FAERS | |
| 199 | Restless Legs Syndrome | FAERS: 1 | US FAERS | |
| 200 | Restlessness | FAERS: 1 | US FAERS | |
| 201 | Retching | FAERS: 1 | US FAERS | |
| 202 | Skin indentation | FAERS: 1 | US FAERS | |
| 203 | Skin irritation | FAERS: 1 | US FAERS | |
| 204 | Skin laceration | FAERS: 1 | US FAERS | |
| 205 | Skin lesion | FAERS: 1 | US FAERS | |
| 206 | Sunburn | FAERS: 1 | US FAERS | |
| 207 | Syringe issue | FAERS: 1 | US FAERS | |
| 208 | Throat irritation | FAERS: 1 | US FAERS | |
| 209 | Urinary tract infection | FAERS: 1 | US FAERS | |
| 210 | Visual Impairment | FAERS: 1 | US FAERS | |
| 211 | Weight decreased | FAERS: 1 | US FAERS | |
| 212 | White blood cell count decreased | FAERS: 1 | US FAERS | |
| 213 | nervous system disorder | FAERS: 1 | US FAERS |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.